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 
Abstract—In this letter, we propose a dielectric-modulated 
Impact-Ionization MOS (DIMOS) transistor based sensor for 
application in label-free detection of biomolecules. Numerous 
reports exist on the experimental demonstration of nanogap-
embedded FET-based biosensors, but an I-MOS based biosensor 
has not been reported previously. The concept of a dielectric-
modulated I-MOS based biosensor is presented in this letter 
based on TCAD simulation study. The results indicate a high 
sensitivity to the presence of biomolecules even at small channel 
lengths. In addition, a low variability of the sensitivity to the 
charges on the biomolecule is observed. The high sensitivity, 
dominance of dielectric-modulation effects and operation at even 
small channel lengths makes the DIMOS biosensor a promising 
alternative for CMOS-based sensor applications. 
 
Index Terms—Biomolecule, charge, dielectric modulated FET 
(DMFET), impact ionization MOS (I-MOS), nanogap, sensor. 
I. INTRODUCTION 
he application of FET as a biosensor for label-free 
detection of charged biomolecules has seen significant 
usage [1-3]. The use of the concept of dielectric modulation of 
a vertical nanogap  in the FET’s gate due to the presence of 
biomolecules has enabled the application of FET biosensors 
for detecting the presence of charge-free biomolecules as well 
[4-8]. The reported dielectric-modulated FET (DMFET) based 
biosensors show high responsiveness to both dielectric 
modulation and charge of the biomolecules, with the two 
effects often affecting the device parameters in opposite 
directions leading to reduced sensitivity [8]. In addition, the 
DMFET shows a sharp dependence of the sensitivity of 
biomolecule detection to the nanogap length and a significant 
fall in sensitivity for short channel lengths [8]. In this letter, 
we propose, for the first time, the application of impact-
ionization MOS (I-MOS) transistor as a bio-sensor. A 
conventional I-MOS is a gated p-i-n diode, with the gate 
voltage modulating the channel inversion charge and causing 
the drain-source voltage to appear across the intrinsic region 
outside the gate region [9, 10]. On reaching a critical value, 
the electrical field in the intrinsic region causes impact-
ionization leading to an abrupt turning-ON of the I-MOS 
transistor [11, 12]. Recent results have shown a sub-threshold 
slope as low as 2-10 mV/dec [13-15]. 
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In this letter, using TCAD simulation [16], we examine the 
performance of a Dielectric modulated I-MOS transistor 
(DIMOS) as a label-free biosensor. By introducing a nanogap 
using a combination of gold and chromium gate structure [4] 
in the I-MOS device, we demonstrate the DIMOS to be a 
highly sensitive bio-sensor with potential applications in bio-
medical field for sensing bio-molecules. 
II. DEVICE STRUCTURE AND BIOSENSING ACTION 
The structure of the conventional p-channel I-MOS [9, 10] 
and p-channel DIMOS are shown in Fig. 1(a) and Fig. 1(b), 
respectively. The parameters used in our simulation are: 
silicon film thickness (TSi)  = 100 nm, silicon film doping = 
2×1015 cm-3, buried oxide thickness (TBOX) = 300 nm, gate-
oxide thickness (Tox) = 5 nm, the nominal channel length (L) = 
200 nm, nanogap thickness (TGAP) = 15 nm, chromium gate 
length (LCr) = 25 nm, work function of chromium (Cr)  = 4.5 
eV, gold gate length (LG) = 125 nm and work function of gold 
(Au)  = 5.1 eV. For the conventional I-MOS, the additional 
parameters used are: the gate length (LG) = 125 nm and the 
gate work function (ΦM ) = 4.6 eV. For both the devices, the 
length of the intrinsic region (LIN) outside the gate region is 75 
nm. The doping profiles in the source and drain region are 
modeled as a Gaussian distribution with the drain acceptor 
doping (NA) and source donor doping (ND) taken as 1020 cm-3. 
The creation of the nanogap in the gate structure has been 
demonstrated experimentally in [4]. After creating the 
nanogap by etching the edges of the chromium gate structure, 
air, with a dielectric constant (K) of 1, fills the nanogap [8]. 
Immobilization of biomolecules (K > 1) in the nanogap causes 
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Fig. 1. Cross sectional view of (a) the conventional I-MOS and (b) the 
DIMOS. 
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the effective dielectric constant to increase, leading to an 
increased gate capacitance and consequently a reduced 
threshold voltage VT. Detection of this VT shift leads to a 
label-free detection of biomolecules [4]-[8]. 
III. SIMULATION RESULTS AND DISCUSSION 
We have simulated the DIMOS biosensor to study the 
sensitivity of the device for detection of the immobilization of 
the nanogap by biomolecules. The immobilization event is 
modeled in the simulation by changing the dielectric constant 
of the nanogap since the biomolecules will have a dielectric 
constant different from air. To represent a group of 
biomolecules with low and high dielectric constants, a value 
of K = 2 and 12 is used, respectively, following the approach 
in [8]. We selected the Selberherr’s Model for impact-
ionization and also included Band-to-Band tunneling effects in 
the simulation.  
Fig. 2. shows the ID vs. VG characteristics of the DIMOS 
biosensor, with VS = 7.8 V and VD = 0 V. A negative sweep is 
applied on the gate as simulation was done on a p-Channel 
DIMOS. In the absence of the biomolecular immobilization 
(K=1), the DIMOS turns on at ~16V as compared to the 
conventional I-MOS turning on at ~1.36V. The higher turn on 
voltage for the DIMOS, compared to the conventional I-MOS, 
is because of the increased dielectric thickness in the nanogap 
region (with K = 1) of the DIMOS. This leads to a reduced 
gate control of the channel increasing the turn on voltage. The 
presence of high dielectric constant biomolecules (K =12) 
causes the VT of DIMOS to fall to 2.29V (~86% VT shift), 
leading to an extremely sensitive biosensor even at small 
channel lengths. Another parameter to be considered for the 
device sensitivity is the On-state current ION which shows an 
increase by thirteen times in the presence of biomolecules 
when compared with the empty nanogap.   
This large shift in VT with nanogap immunization can be 
understood by analyzing the transverse electric field profile 
along the channel of the DIMOS, as shown in Fig. 3. The I-
MOS turns-on because of the impact ionization caused by high 
horizontal electric field in the intrinsic region [10]. The empty 
nanogap results in a low inversion in the channel region under 
the nanogap, causing VSD to appear across a longer length of 
the silicon film. This results in the impact ionization setting in 
at a much higher gate voltage. With the biomolecule 
immunization and consequent dielectric-modulation of the 
nanogap, sufficient inversion occurs in the channel region 
under the nanogaps. As a result, VSD  now appears across a 
shorter length of the silicon film. This will make the electric 
field profile of the DIMOS similar to that of the conventional 
I-MOS leading to a reduction in VT of the DIMOS. 
A. Effect of Gate Length (LG) at a fixed Cr Gate Length (LCr) 
We simulated the DIMOS biosensor to find the optimum 
value of LG such that the sensitivity to biomolecular 
immobilization is maximized. The variation of ∆VT and ∆ION 
for different values of LG is shown in Fig. 4. For LG = 115 nm, 
the device seems to be most sensitive if VT shift is chosen as 
the sensing parameter.  DMFETs with a channel length of 300 
nm have been shown to have less sensitivity [8]. However, the 
proposed DIMOS with a channel length of 200 nm exhibits 
high sensitivity indicating that this device can be scaled down 
to smaller dimensions. We have also simulated the DIMOS at 
a channel length (L) of 1 µm and the biosensing action 
remains valid, thus showing the applicability of the DIMOS 
concept across process technology nodes. 
B. Impact of Biomolecular charges 
The DMFET biosensing action is significantly affected by 
the presence of charges in the biomolecules. Depending on the 
polarity of charges, the device type (PMOS or NMOS) may 
have to be changed [7]. We studied the impact of biomolecule 
charges on the performance of the DIMOS biosensors, 
choosing LG = 115 nm since this is the optimum value for 
maximum device sensitivity. Fig. 5 shows the variation in ∆VT 
and ∆ION for a range of biomolecular charges [5]. The 
biomolecular charges have been modeled as point charges at 
the silicon-oxide interface. Compared to the conventional 
 
Fig. 2.  P-channel DIMOS ID vs. VG characteristics. 
 
 
Fig. 3.  Horizontal electric field (EX) profile along the x-axis. 
 
 
Fig. 4.  ∆VT and ∆ION for the DIMOS as a function of gate length, LG. 
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DMFET where the charge effect can even dominate over the 
dielectric-modulation effect [7], the DIMOS shows negligible 
variation in the sensitivity to biomolecular charges. The 
dominance of the dielectric-modulation effect in DIMOS 
enables the use of the same device type (p-channel or n-
channel) for detecting biomolecules of opposite charge 
polarities which is not possible in the conventional DMFETs. 
IV. CONCLUSION 
We have proposed and analyzed the concept of a dielectric-
modulated impact-ionization MOS (DIMOS) biosensor. The 
proposed structure demonstrates high sensitivity for 
biomolecule detection and retains dielectric-modulation as the 
dominant effect, as opposed to the conventional DMFETs 
where the impact of biomolecule charges on the device 
sensitivity is significant. The proposed sensor device shows 
good scalability across process technology nodes and can be 
an exciting alternative to FET biosensors for both advanced 
technology nodes as well as the older technology nodes where 
low-cost is the driving factor.  
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Fig. 5.  ∆VT and ∆ION of the p-channel DIMOS for negatively charged 
biomolecules. 
 
 
